144 related articles for article (PubMed ID: 8775620)
41. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
[TBL] [Abstract][Full Text] [Related]
42. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
43. Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats.
Sadoshima S; Ooboshi H; Okada Y; Yao H; Ishitsuka T; Fujishima M
Eur J Pharmacol; 1989 Oct; 169(1):75-83. PubMed ID: 2513212
[TBL] [Abstract][Full Text] [Related]
44. Thromboxane A2 synthetase inhibitor (OKY-046) improves abnormal mucociliary transport in asthmatic patients.
Kurashima K; Ogawa H; Ohka T; Fujimura M; Matsuda T
Ann Allergy; 1992 Jan; 68(1):53-6. PubMed ID: 1736720
[TBL] [Abstract][Full Text] [Related]
45. Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
Komatsu H; Takehana Y; Hamano S; Ujiie A; Hiraku S
Jpn J Pharmacol; 1986 Jul; 41(3):381-91. PubMed ID: 3761754
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.
Chung KF; Aizawa H; Becker AB; Frick O; Gold WM; Nadel JA
Am Rev Respir Dis; 1986 Aug; 134(2):258-61. PubMed ID: 3509981
[TBL] [Abstract][Full Text] [Related]
47. Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor.
Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirbe K; Shimada M; Sugimachi K
J Surg Res; 1996 May; 62(2):216-23. PubMed ID: 8632642
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of sequential perfusion with Euro-Collins and Belzer solutions for pancreas preservation in rats.
Schraibman V; Goldenberg A; Koh IH; Gonzalez AM; Molinari A; de Morais EC; Artigiani R; Matos D
Transplant Proc; 2006 Nov; 38(9):2780-3. PubMed ID: 17112828
[TBL] [Abstract][Full Text] [Related]
49. The mechanism of action of the two-layer (Euro-Collins' solution/perfluorochemical) cold-storage method in canine pancreas preservation--the effect of 2,4 dinitrophenol on graft viability and adenosine triphosphate tissue concentration.
Kuroda Y; Fujino Y; Morita A; Tanioka Y; Ku Y; Saitoh Y
Transplantation; 1992 May; 53(5):992-4. PubMed ID: 1585492
[TBL] [Abstract][Full Text] [Related]
50. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.
Takahashi T
Surg Today; 1996; 26(1):15-20. PubMed ID: 8680115
[TBL] [Abstract][Full Text] [Related]
51. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
Ohsugi S
Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476
[No Abstract] [Full Text] [Related]
52. [Effect of thromboxane A2 synthetase inhibitor and prostacyclin analogue on arterial blood pressure, fibrinolysis and platelet function in patients with hypertension].
Nizankowski R; Krzanowski M; Musiał J; Szczeklik A
Pol Tyg Lek; 1991 Jan 7-14; 46(1-3):18-21. PubMed ID: 1726988
[TBL] [Abstract][Full Text] [Related]
53. Functional and structural integrity of porcine pancreatic grafts subjected to a period of warm ischemia and cold preservation with histidine-tryptophan-ketoglutarate (custodiol) or University of Wisconsin solution.
Troisi R; Meester D; Van Den Broecke C; Cuvelier CA; Fiers T; de Hemptinne B; Hesse UJ
Transplantation; 2003 Jun; 75(11):1793-9. PubMed ID: 12811236
[TBL] [Abstract][Full Text] [Related]
54. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
Sasaki T; Wakai S; Asano T; Takakura K; Sano K
J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
[TBL] [Abstract][Full Text] [Related]
55. Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia.
Cambria RA; Anderson RJ; Dikdan G; Lysz TW; Hobson RW II
Am Surg; 1991 Feb; 57(2):76-9. PubMed ID: 1847027
[TBL] [Abstract][Full Text] [Related]
56. Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm.
Takeuchi H; Tanabe M; Okamoto H; Yamazaki M
Neurol Res; 1999 Jul; 21(5):513-6. PubMed ID: 10439434
[TBL] [Abstract][Full Text] [Related]
57. Selective thromboxane A2 synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injury.
Westphal M; Noshima S; Isago T; Fujioka K; Maybauer MO; Maybauer DM; Traber LD; Flynn JT; Westphal-Varghese BB; Traber DL
Anesthesiology; 2005 May; 102(5):954-61. PubMed ID: 15851882
[TBL] [Abstract][Full Text] [Related]
58. Reduction of chronic ciclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046.
Kim YJ; Park YH; Moon HK
Kidney Blood Press Res; 1997; 20(1):38-43. PubMed ID: 9192909
[TBL] [Abstract][Full Text] [Related]
59. Correlation between high adenosine triphosphate tissue concentration and good posttransplant outcome for the canine pancreas graft after preservation by the two-layer cold storage method.
Kuroda Y; Fujino Y; Morita A; Ku Y; Saitoh Y
Transplantation; 1991 Dec; 52(6):989-91. PubMed ID: 1750085
[TBL] [Abstract][Full Text] [Related]
60. The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
Iida T; Yokoi H; Kawarada Y
Pancreas; 1998 Aug; 17(2):140-7. PubMed ID: 9700944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
